Galectin‐3 and risk of cardiovascular events and all‐cause mortality in type 2 diabetes - Tan, Kathryn C.B.; Cheung, Ching‐Lung; Lee, Alan C.H.; Lam, Joanne K.Y.; Wong, Ying; Shiu, Sammy W.M. (Diabetes/metabolism research and reviews, 2019)
Keywords: all‐cause mortality; Atherogenesis; Biomarkers - blood; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - etiology; Cardiovascular Diseases - mortality; cardiovascular outcome; Cerebral infarction; Congestive heart failure; Coronary artery disease; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - mortality; Diuretics; Epidermal growth factor receptors; Female; Follow-Up Studies; Galectin 3 - blood; galectin‐3; Health risk assessment; Humans; Male; Middle Aged; Mortality; Myocardial infarction; Prognosis; Risk Factors; Survival Rate; type 2 diabetes; type 2 diabetes; cardiovascular outcome; galectin-3; all-cause mortality